MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $201,000 | +491.2% | 3,346 | +482.9% | 0.00% | +200.0% |
| Q1 2016 | $34,000 | -94.9% | 574 | -95.8% | 0.00% | -92.9% |
| Q4 2015 | $661,000 | -59.6% | 13,562 | -63.1% | 0.01% | -64.1% |
| Q3 2015 | $1,636,000 | -77.0% | 36,762 | -41.0% | 0.04% | -75.8% |
| Q2 2015 | $7,117,000 | +71070.0% | 62,324 | +207646.7% | 0.16% | – |
| Q1 2015 | $10,000 | +25.0% | 30 | +400.0% | 0.00% | – |
| Q4 2014 | $8,000 | -27.3% | 6 | 0.0% | 0.00% | – |
| Q3 2014 | $11,000 | -98.7% | 6 | -99.9% | 0.00% | -100.0% |
| Q2 2014 | $875,000 | -34.4% | 11,294 | -30.9% | 0.02% | -34.5% |
| Q1 2014 | $1,334,000 | -25.0% | 16,355 | -39.2% | 0.03% | -19.4% |
| Q4 2013 | $1,778,000 | -42.8% | 26,906 | -40.9% | 0.04% | -47.8% |
| Q3 2013 | $3,107,000 | +32.8% | 45,537 | +14.9% | 0.07% | +15.0% |
| Q2 2013 | $2,340,000 | – | 39,623 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |